Dr. Tarik Messaoud is a physician, international pharmacovigilance consultant, advisor, and speaker who regularly contributes to major drug safety congresses across North America and Europe. He holds a Graduate Diploma in Clinical Research and Clinical Trial Management from the Université de Montréal, Canada. With 16 years of pharmacovigilance experience in Canada and the United States, Dr. Messaoud specializes in oncology drug safety, particularly immunotherapy, adoptive cell therapy, and immune checkpoint inhibitor–based cancer treatments. His career includes medical and drug safety leadership roles at Merck/MSD, GlaxoSmithKline, and Iovance Biotherapeutics, with a strong focus on patient safety and benefit–risk management.